KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
University of Chicago
Tianjin Medical University Cancer Institute and Hospital
Roswell Park Cancer Institute
Massachusetts General Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
HonorHealth Research Institute
M.D. Anderson Cancer Center
Icahn School of Medicine at Mount Sinai
Institut du Cancer de Montpellier - Val d'Aurelle
Second Affiliated Hospital, School of Medicine, Zhejiang University
Sichuan Enray Pharmaceutical Sciences Company
Icahn School of Medicine at Mount Sinai
Essen Biotech
Essen Biotech
Roswell Park Cancer Institute
Institut du Cancer de Montpellier - Val d'Aurelle
City of Hope Medical Center
Second Affiliated Hospital, School of Medicine, Zhejiang University
M.D. Anderson Cancer Center
University of Pittsburgh
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
University of Chicago
AIO-Studien-gGmbH
Hadassah Medical Organization
Korea University Anam Hospital
Sun Yat-sen University
Fudan University
The Netherlands Cancer Institute
The Netherlands Cancer Institute
University of Southern California
Amsterdam UMC, location VUmc
Cancer Research UK
Centre Georges Francois Leclerc
Tongji Hospital
Massachusetts General Hospital
Thomas Jefferson University
Esperas Pharma Inc.
First Affiliated Hospital of Chongqing Medical University
NuCana plc
Radboud University Medical Center
Sun Yat-sen University
Sichuan Cancer Hospital and Research Institute
Sarcoma Oncology Research Center, LLC
Centre Georges Francois Leclerc
Biotech Pharmaceutical Co., Ltd.